文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

URB602抑制单酰甘油脂肪酶可减轻大鼠心脏骤停模型的心肌损伤

Monoacylglycerol Lipase Inactivation by Using URB602 Mitigates Myocardial Damage in a Rat Model of Cardiac Arrest.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论在大鼠窒息性心脏骤停复苏后1分钟单次静脉给予URB602(5 mg/kg)可显著提高168小时生存率(63.6% vs 31.8%),并减轻心肌与线粒体损伤。

该研究为前瞻性随机实验室研究,采用96只雄性Sprague-Dawley大鼠建立8分钟窒息性心脏骤停与心肺复苏模型,复苏成功后随机分为心肺复苏+URB602组、心肺复苏组和假手术组。复苏成功后1分钟,URB602组单次给予URB602(5 mg/kg),心肺复苏组给予等体积溶剂。URB602组168小时生存率63.6%,显著高于溶剂对照组的31.8%;复苏后6小时URB602显著减轻心肌损伤和线粒体损伤,并减轻内源性大麻素与类花生酸代谢紊乱;复苏后15分钟URB602防止线粒体通透性转换加速。作者认为单酰甘油脂肪酶阻断可能减轻心肌和线粒体损伤并显著改善心肺复苏效果。

要点

  • 大鼠窒息性心脏骤停8分钟后复苏,复苏成功后1分钟单次给予URB602(5 mg/kg),168小时生存率63.6%,溶剂对照组31.8%。
  • 复苏后6小时,URB602显著减轻心肌损伤并防止心肌线粒体损伤。
  • 复苏后6小时,URB602减轻内源性大麻素与类花生酸代谢紊乱。
  • 复苏后15分钟,URB602防止线粒体通透性转换加速。
  • 作者认为单酰甘油脂肪酶阻断可能减轻心肌和线粒体损伤并改善复苏效果。

适用人群与场景

  • 雄性Sprague-Dawley大鼠(n=96),经历8分钟窒息性心脏骤停与心肺复苏后存活者。
  • 假手术组接受与心肺复苏组和心肺复苏+URB602组相同的全部操作,但不进行心脏骤停和窒息。

处置流程与药物剂量

  • 复苏成功后1分钟,心肺复苏+URB602组单次给予URB602 5 mg/kg,为小分子单酰甘油脂肪酶抑制剂;心肺复苏组给予等体积溶剂溶液。

研究设计与关键结果

  • 研究类型:前瞻性随机实验室研究,样本量96只雄性Sprague-Dawley大鼠,大学研究实验室。
  • 干预与对照:8分钟窒息性心脏骤停与复苏后存活大鼠随机分为心肺复苏+URB602组、心肺复苏组和假手术组;复苏成功后1分钟URB602组单次给予URB602(5 mg/kg),心肺复苏组给予等体积溶剂。
  • 主要终点:复苏后168小时生存率,URB602组63.6% vs 溶剂对照组31.8%(每组n=22)。
  • 关键次要终点:复苏后6小时,URB602显著减轻心肌损伤并防止心肌线粒体损伤;复苏后6小时URB602减轻内源性大麻素与类花生酸代谢紊乱;复苏后15分钟URB602防止线粒体通透性转换加速。

证据类型、等级与局限

  • 证据类型:前瞻性随机实验室研究(大鼠模型)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为单酰甘油脂肪酶阻断可能减轻心肌和线粒体损伤并显著改善心脏骤停与心肺复苏后的复苏效果。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Monoacylglycerol lipase participates in organ protection by regulating the hydrolysis of the endocannabinoid 2-arachidonoylglycerol. This study investigated whether blocking monoacylglycerol lipase protects against postresuscitation myocardial injury and improves survival in a rat model of cardiac arrest and cardiopulmonary resuscitation.

DESIGN: Prospective randomized laboratory study.

SETTING: University research laboratory.

SUBJECTS: Male Sprague-Dawley rat (n = 96).

INTERVENTIONS: Rats underwent 8-minute asphyxia-based cardiac arrest and resuscitation. Surviving rats were randomly divided into cardiopulmonary resuscitation + URB602 group, cardiopulmonary resuscitation group, and sham group. One minute after successful resuscitation, rats in the cardiopulmonary resuscitation + URB602 group received a single dose of URB602 (5 mg/kg), a small-molecule monoacylglycerol lipase inhibitor, whereas rats in the cardiopulmonary resuscitation group received an equivalent volume of vehicle solution. The sham rats underwent all of the procedures performed on rats in the cardiopulmonary resuscitation and cardiopulmonary resuscitation + URB602 groups minus cardiac arrest and asphyxia.

MEASUREMENTS AND MAIN RESULTS: Survival was recorded 168 hours after the return of spontaneous circulation (n = 22 in each group). Compared with vehicle treatment (31.8%), URB602 treatment markedly improved survival (63.6%) 168 hours after cardiopulmonary resuscitation. Next, we used additional surviving rats to evaluate myocardial and mitochondrial injury 6 hours after return of spontaneous circulation, and we found that URB602 significantly reduced myocardial injury and prevented myocardial mitochondrial damage. In addition, URB602 attenuated the dysregulation of endocannabinoid and eicosanoid metabolism 6 hours after return of spontaneous circulation and prevented the acceleration of mitochondrial permeability transition 15 minutes after return of spontaneous circulation.

CONCLUSIONS: Monoacylglycerol lipase blockade may reduce myocardial and mitochondrial injury and significantly improve the resuscitation effect after cardiac arrest and cardiopulmonary resuscitation.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Hai K, Chen G, Gou X, et al. Monoacylglycerol Lipase Inactivation by Using URB602 Mitigates Myocardial Damage in a Rat Model of Cardiac Arrest. Crit Care Med. 2019. PMID: 30431495. doi:10.1097/CCM.0000000000003552

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。